Galectin-9: A novel promoter of atherosclerosis progression is a research paper published in Atherosclerosis (2022). On theSindex it has a DataRank of 0.968. It has been cited 35 times, with 30 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.538
From this paper's citation signal
Citation Network Contribution
0.431
From 25 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 30 citers.
Versus Arthritis
Grant: 20,387
National Institutes of Health
Grant: P01 HL131481
National Institutes of Health
Grant: R01 HL084312
Medical Research Council
Grant: MR/P016154/1
Regulation of leukocyte recruitment by fibroblast-endothelial interactions: Dissecting the stromal switch from resolution to persistent inflammation
Medical Research Council
Grant: MR/T028025/1
New therapeutic avenues in inflammatory arthritis: exploring the role of the adiponectin-PEPITEM pathway
British Heart Foundation
Grant: AA/18/2/34,218
Academy of Medical Sciences
Grant: SBF003\1156
Versus Arthritis
Grant: 20387
FWCI
2.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals